MCG for Localization of Tachyarrhythmia's Origin

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT06327425

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06327425
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06327425. Non-randomized; no masking; primary purpose diagnostic. Start 2024-03-14 (actual); primary completion 2024-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MCG for Localization of Tachyarrhythmia's Origin
Condition
Tachyarrhythmia
Condition
Paroxysmal Supraventricular Tachycardia
Condition
Atrial Tachycardia
Condition
Premature Ventricular Contraction
Intervention (Device)
Magnetocardiography
Lead sponsor
Qilu Hospital of Shandong University (class: other)

Record details

Record id
cardio:ct-nct06327425
Content hash
0502df363303359c3444b0b92379161460286706a97bef61cdb32c24d15c8126